Open-label, Prospective Exploratory Study to Assess the Effects of Formoterol and Beclometasone Dipropionate Combination Therapy on Central and Peripheral Airway Dimensions in COPD Patients
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2014
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 02 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 02 Jul 2012 Actual patient number is 29 according to ClinicalTrials.gov.
- 02 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.